Skip to main content
. 2019 Oct 15;12:219–228. doi: 10.2147/IJNRD.S216010

Table 2.

Clinical Characteristics Of CKD Patients (N=251)

Variables Frequency (%) Anemia P-value
Present Absent
Treatment status for anemia
 Yes 42 (16.7) 42 0 <0.001
 No 209 (83.3) 120 89
Type of treatment for treated cases
 Blood transfusion (BT) 19 19 0 ?
 Hematinics only 14 14 0
 BT and hematinics 3 3 0
 Hematinics and ESA 5 5 0
 BT, hematinics, and ESA 1 1 0
Smoking
 Yes 13 (5.2) 7 6 0.408
 No 238 (94.8) 155 83
Alcohol drinking
 Yes 61 (24.3) 39 22 0.909
 No 190 (75.7) 123 67
Presence of comorbidity
 Yes 88 (35.1) 58 60 0.014
 No 163 (64.9) 104 59
Taking other medicationsa
 Yes 212 (84.1) 132 79 0.132
 No 40 (15.9) 30 10
Family history of kidney disease
 Yes 10 (4.0) 9 1 0.085
 No 241 (96.0) 153 88
Underlying cause of CKD
 Chronic GN 60 (23.9) 54 6 <0.001
 Hypertension 115 (45.4) 66 48
 Diabetes 51 (20.9) 23 28
 Others 26 (9.8) 20 6
Hemodialysis history
 Yes 32 (12.7) 26 6 0.034
 No 219 (87.3) 136 83
SBP category (mmHg)
 ≥160 38 (15.1) 22 16 0.151
 150–159 68 (27.1) 41 27
 120–139 85 (33.9) 53 32
 90–119 60 (23.9) 46 14
DBP category (mmHg)
 ≥100 21 (8.4) 16 5 0.033
 90–99 52 (20.7) 31 21
 80–89 70 (27.9) 37 33
 60–79 108 (43.0) 78 30
BMI (kg/m2)
 <18.5 43 (17.1) 35 8 <0.001
 18.5–24.9 160 (63.7) 109 51
 25–29.9 31 (12.4) 14 17
 ≥30 17 (6.8) 4 13

Note: aACE inhibitors, calcium channel blockers, diuretics, insulin, oral antidiabetic drugs (metformin, glibenclamide), ASA and statins.